Cromos Pharma supporting clinical trials to advance HIV treatments
World AIDS Day, observed every year on December 1st, is an international day dedicated to raising awareness of HIV/AIDS, remembering those who have died, and showing support for the millions living with HIV/AIDS.
HIV/AIDS Global Statistics[i]
- 2021 marks the 33rd year of World AIDS Day which was first established by the UN in 1988. It also marks 40 years since the first reports of HIV and AIDS in 1981.
- Over 79.3 million people have become infected with HIV and over 36 million people have died from AIDS-related illnesses since the start of the epidemic.
- Approximately 37.7 million people are currently living with HIV, with 1.5 million people newly infected in 2020. In 2020, 680,000 people died from AIDS-related illnesses.
- In 2021, over 28 million people were accessing antiretroviral therapy.
- Over 53% of all those living with HIV are women and girls.
Development of treatments
World AIDS Day provides an opportunity to recognize the role that clinical research continues to play in developing treatments and therapies that radically reduce mortality and improve the lives of patients worldwide.
In 1987, AZT, the first antiretroviral treatment, was licensed for use in the USA. More successful treatments followed in the 1990s and 2000s. Protease inhibitors were subsequently developed which radically decreased the progression of HIV to AIDS and drastically reduced mortality. Today, people diagnosed with HIV can choose from over 40 medications and given the right combination, live long and healthy lives. However, the fight continues to ensure wider access to these revolutionary drugs, especially in low income countries.
Sponsors and CROs continue to play a central role in the fight against HIV/AIDs
Advancements in HIV treatment would not have been possible without clinical trials and HIV patients volunteering to participate in them. Clinical research continues to develop more advanced treatments and significant efforts are being made to make HIV treatments more widely available. Recently, clinical trial researchers have been developing new treatments aimed at eliminating the need for daily medication as well as immunotherapy and cell therapy treatments.
Cromos Pharma and HIV-related clinical trials
Cromos Pharma has managed dozens of HIV-related clinical trials since 2004. We are pleased to support World AIDS Day to help reduce stigma and show solidarity with those living with HIV/AIDS. We are proud to play our part in advancing new treatments and the development of affordable generics to help increase access to therapies.